Literature DB >> 1575007

Early prognostic factors for disability in multiple sclerosis, a European multicenter study.

T Riise1, M Grønning, O Fernández, K Lauer, R Midgard, J M Minderhoud, H Nyland, G Pálffy, S Poser, J A Aarli.   

Abstract

The effects of initial clinical variables on short-term prognosis are analyzed in a cross-sectional study of 574 multiple sclerosis patients from 7 centers in 5 European countries. Patients with a primary progressive course had a 2.3 higher mean disability score (EDSS) than the primary remittent group after a mean duration of disease of 6.6 years. High age at onset was associated with a primary progressive course, and was also related to increased risk of a rapid shift to a secondary progressive course. Among the remittent patients without a secondary progressive course a high age at onset was significantly correlated to a higher disability score. In the whole remittent group the presence of pyramidal and cerebellar symptoms at onset predicted both a high disability score and a rapid shift to a secondary progression, while the effect was reverse for sensory and visual symptoms. No difference between the sexes was found.

Entities:  

Mesh:

Year:  1992        PMID: 1575007     DOI: 10.1111/j.1600-0404.1992.tb04031.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  16 in total

1.  Metabolic disturbances in the gray matter of the human brain in autoimmune demyelinating disease of the nervous system and their contribution to the symptomatology of the disease.

Authors:  L N Prakhova; A G Il'ves; G V Kataeva; M S Rudas; N A Totolyan; I D Stolyarov
Journal:  Dokl Biol Sci       Date:  2002 Sep-Oct

Review 2.  Multiple sclerosis in the elderly patient.

Authors:  Amer Awad; Olaf Stüve
Journal:  Drugs Aging       Date:  2010-04-01       Impact factor: 3.923

3.  Impact of multiple sclerosis relapses on progression diminishes with time.

Authors:  H Tremlett; M Yousefi; V Devonshire; P Rieckmann; Y Zhao
Journal:  Neurology       Date:  2009-11-04       Impact factor: 9.910

4.  A preliminary longitudinal study of the retinal nerve fiber layer in progressive multiple sclerosis.

Authors:  Andrew P D Henderson; S A Trip; P G Schlottmann; D R Altmann; D F Garway-Heath; G T Plant; D H Miller
Journal:  J Neurol       Date:  2010-02-09       Impact factor: 4.849

5.  Impairment, disability, and handicap in multiple sclerosis. A cross-sectional study in an incident cohort in Møre and Romsdal County, Norway.

Authors:  R Midgard; T Riise; H Nyland
Journal:  J Neurol       Date:  1996-04       Impact factor: 4.849

6.  Multivariate analysis of predictive factors of multiple sclerosis course with a validated method to assess clinical events.

Authors:  M Trojano; C Avolio; C Manzari; A Calò; F De Robertis; G Serio; P Livrea
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-03       Impact factor: 10.154

7.  Age and disability accumulation in multiple sclerosis.

Authors:  A Scalfari; A Neuhaus; M Daumer; G C Ebers; P A Muraro
Journal:  Neurology       Date:  2011-09-14       Impact factor: 9.910

8.  Signal transducer and activator of transcription-3/suppressor of cytokine signaling-3 (STAT3/SOCS3) axis in myeloid cells regulates neuroinflammation.

Authors:  Hongwei Qin; Wen-I Yeh; Patrizia De Sarno; Andrew T Holdbrooks; Yudong Liu; Michelle T Muldowney; Stephanie L Reynolds; Lora L Yanagisawa; Thomas H Fox; Keun Park; Laurie E Harrington; Chander Raman; Etty N Benveniste
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-12       Impact factor: 11.205

9.  Pre-existing central nervous system lesions negate cytokine requirements for regional experimental autoimmune encephalomyelitis development.

Authors:  Xin Li; Jason R Lees
Journal:  Immunology       Date:  2013-03       Impact factor: 7.397

10.  Prediction of outcome in multiple sclerosis based on multivariate models.

Authors:  B Runmarker; C Andersson; A Odén; O Andersen
Journal:  J Neurol       Date:  1994-10       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.